Literature DB >> 21920876

A two-stage estimation for screening studies using two diagnostic tests with binary disease status verified in test positives only.

Feng Li1, Haitao Chu2, Lei Nie3.   

Abstract

This article considers the statistical estimation and inference for screening studies in which two binary tests are used for screening with a binary disease status verified only for those subjects with at least one positive test result. The challenge encountered in these studies is the non-identifiability because the disease rate is not identifiable for subjects with negative results from both tests without additional assumptions. Different homogeneous association models have been proposed in the literature to circumvent the non-identifiability problem, which were solved using numerical methods. We propose to formulate the problem as a constrained maximum likelihood estimation (MLE) problem. The MLE has a closed-form in general, which can be solved using a unified two-stage estimation approach. We demonstrate the application of the proposed method on a set of homogeneous association models. The homogeneous association assumptions are generally not testable as all models are saturated. Therefore, we propose an association-ratio plot as a visualization tool for model comparisons. The methods are illustrated through three examples.
© The Author(s) 2011.

Keywords:  dependence; diagnostic test accuracy; homogeneous association; screening studies

Mesh:

Year:  2011        PMID: 21920876     DOI: 10.1177/0962280211421838

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  2 in total

1.  Prevalence estimation when disease status is verified only among test positives: Applications in HIV screening programs.

Authors:  Emma G Thomas; Sarah B Peskoe; Donna Spiegelman
Journal:  Stat Med       Date:  2017-12-11       Impact factor: 2.373

2.  A two-stage Bayesian method for estimating accuracy and disease prevalence for two dependent dichotomous screening tests when the status of individuals who are negative on both tests is unverified.

Authors:  Jin Liu; Feng Chen; Hao Yu; Ping Zeng; Liya Liu
Journal:  BMC Med Res Methodol       Date:  2014-09-23       Impact factor: 4.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.